Topics:

Rheumatology Network

Tech Tips Series #1: Managing the Information Barrage

Our goal at RheumNet is always to help you manage the constant flood of online information for rheumatologists. Here, in the first installment of a new series, Advisory Board member Suleman Bhana MD shares tips for saving, sorting, and retrieving journal articles.

Recent Content

Rheumatology tests top the list of FDA-approved biomarker panels today. But the most prominent of these has fallen from favor, and rheumatology doesn't even rate a mention in the Precision Medicine Initiative.

medication risks

When it comes to discussing medication risks, a new study shows, rheumatologists and their patients are speaking different languages. The article reveals how doctors may be sending messages they don't intend.

retinopathy

About half of patients taking hydroxychloroquine, which is used for lupus and rheuamtoid arthritis, aren't tested in time for its blinding effects on the retina, says a review. There are simple ways to use the drug safely.

psoriatic arthritis

Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.

Articles in two different internal medicine journals last week discussed when and how to use opioids for rheumatologic pain, despite their hazards and limitations.

The JAK1 and JAK2 inhibitor baricitinib has shown significant results in a second Phase 3 trial for rheumatoid arthritis.

The first study to ask about variance between physicians and patients in judging the severity of psoriatic arthritis shows that, as with rheumatoid arthritis, they don't reach similar conclusions.

By clicking Accept, you agree to become a member of the UBM Medica Community.